Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Autor: Blanco Echevarría, Agustín, García Díaz, Juan De Dios, Caixas, Assumpta, Plana Gil, Núria, Rico Corral, Miguel Ángel, Bridges, Ian, Dhalwani, Nafeesa, Gatell Menchen, Sònia, Ray, Kausik K.
Zdroj: In Clínica e Investigación en arteriosclerosis (English edition) November-December 2023 35(6):263-271
Databáze: ScienceDirect
Externí odkaz: